NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
16/04/2024
Voltar para busca
Dado oficial do USPTO
INSIGNIA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
54
Atualização mais recente
16/04/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 10, 42
Data de depósito
31/08/2020
Data de registro
16/04/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/04/2024
Última transação
16/04/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
5
Tipo de titular
99
Localização do titular
Eveleigh, AU
Examinador
BAKER, JORDAN A
Unidade examinadora
N60
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the word "INSIGNIA" in stylized form.
Titulares e representantes
Titulares
SpeeDx Pty Ltd
Representantes
Joi A. White Carr & Ferrell LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in industrysciencephotographyagriculturehorticulture and forestryexcept fungicidesherbicidesinsecticidesparasiticides; reagents and reactants for non-medical purposes; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acids for other than medical and veterinary purposes; acidsinorganic acids for industrial purposes; DNA and RNA polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring
Classe 5
Pharmaceutical and veterinary preparations and substances for the diagnosis of diseases or detection or identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and/or immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and/or analysis of epigenetic alterationsanalysis of response to therapy; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes; chemical preparations containing enzymes for pharmaceuticalveterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and/or immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and/or analysis of epigenetic alterationsanalysis of response to therapy; enzymes for pharmaceuticalveterinary and medical purposes; medical kits containing medical and/or pharmaceutical preparations and associated detection reagents for the diagnosis of diseasesfor detection and identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppression and immune disordersfor genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsfor analysis of response to therapy; clinical diagnostics for medical or veterinary use; biological chemical test kits comprised of reagents and assays for medical laboratory use in analysis that test for the presence of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppressionimmune disorders
Classe 10
Surgical apparatus and instruments; medical and veterinary apparatus and instruments for use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; diagnostic testing apparatus and instruments for medical purposesfor use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; diagnostic testing kits containing diagnostic testing apparatus for use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; point of care medical devices for use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; screening kits consisting of medical screening and testing apparatus for the diagnosis of diseasedetection and/or identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune suppression and/or immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and/or analysis of epigenetic alterationsanalysis of response to therapy; all of the foregoing excluding heart pacemakers and stethoscopes and orthopedic implants and excluding apparatusinstruments and devices for use with orthopedic surgery and excluding surgical staplers and accessories therefor
Classe 42
Scientific and technological services and research and design relating theretoin the field of DNA analysis services for scientific research analysisscientific research consulting in the field of genetics; scientific genetic research; genetic engineering services for scientific purposes; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry serviceschemistry research services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; laboratory analysis in the field of chemistry; development of medical diagnostic apparatus; design of medical diagnostic apparatus; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biologicalbacteriologicalchemicalbiochemicalDNARNAproteinpolynucleic acid and molecular analysis and evaluation services for scientific purposes and medical research purposes; DNA and RNA and polynucleic acid and protein sequencinganalysis and evaluation servicesfor scientific purposes and medical research purposes; genome sequencing services and the analysis and evaluation of data resulting therefromfor scientific purposes and medical research purposes; scientific analysis and the provision of reports in conjunction therewith relating to scientific and medical experimentsrelating to the results of scientific and medical experiments and testsrelating to the analysis and evaluation of scientific and medical datarelating to data generated by scientific and medical experiments and tests; scientific and medical research and development services in the field of medical research and genetics; custom design and development of biochemical assays
Publicações
Histórico de despachos e eventos da marca no USPTO.
54 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
16/04/2024
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
11/03/2024
CHPB
POST PUBLICATION AMENDMENT - ENTERED
22/02/2024
APET
ASSIGNED TO PETITION STAFF
20/02/2024
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
23/01/2024
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
19/01/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/01/2024
PUBO
PUBLISHED FOR OPPOSITION
02/01/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/12/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/09/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
19/09/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
19/09/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
19/09/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
19/09/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
12/09/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
05/09/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/08/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
21/08/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
21/08/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
21/08/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
21/08/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/08/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/08/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
18/08/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
31/05/2023
GNFR
FINAL REFUSAL E-MAILED
31/05/2023
CNFR
FINAL REFUSAL WRITTEN
31/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/05/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
14/02/2023
GNRT
NON-FINAL ACTION E-MAILED
14/02/2023
CNRT
NON-FINAL ACTION WRITTEN
14/02/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/08/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
27/07/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
22/07/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
20/01/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
22/07/2021
GNSL
LETTER OF SUSPENSION E-MAILED
22/07/2021
CNSL
SUSPENSION LETTER WRITTEN
22/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/07/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/07/2021
ALIE
ASSIGNED TO LIE
21/07/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
06/07/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/07/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/01/2021
GNRT
NON-FINAL ACTION E-MAILED
05/01/2021
CNRT
NON-FINAL ACTION WRITTEN
05/01/2021
DOCK
ASSIGNED TO EXAMINER
04/01/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/10/2020
NWAP
NEW APPLICATION ENTERED
03/09/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace INSIGNIA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.